Injectable sponge-like gel enhances the quantity and quality of T-cells

New advances selectively suppress damaged cells, allowing for transplants without chemotherapy or radiation

New protocol produces large numbers of mature human podocytes, enabling kidney disease modeling, drug discovery, and potential cell therapies

Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment